PREMIUM!

Single-shot Covid-19 vaccine could be here by next year

Covid-19 2 months ago

Johnson & Johnson’s Janssen Pharmaceutical Companies are moving into phase three of its trials, in a study that aim at obtaining representations of populations which were disproportionately impacted by the pandemic.


25 Sep 2020
PREMIUM!
Single-shot Covid-19 vaccine could be here by next year

A lab technician in Personal Protective Equipment (PPE) looks at a reagent bottle before performing vaccine tests at French pharmaceutical giant Sanofi's lab in Val de Reuil. AFP/JOEL SAGET

A Covid-19 vaccine could be available as early as next year, with Johnson & Johnson moving to the final stage of clinical trials for a single-shot dose, and South Africa is expected to participate. The single-shot vaccine is being developed by Johnson & Johnson’s Janssen Pharmaceutical Companies, and the trial will study the safety and efficacy of a single vaccine dose compared to a placebo, when it comes to preventing Covid-19. The study would aim at obtaining representations of populations which were disproportionately impacted by the pandemic, taking part across three continents which aimed to enroll participants from South Africa,...

BACK TO CITIZEN BACK TO PREMIUM


Black Friday



today in print